|
|
 |
|
Viewing report
|
|
|
|
Epidemiology: Lupus
Datamonitor, March 2011, Pages: 34
Introduction
In 2010, it is estimated that there were about 404,300 prevalent cases of systemic lupus erythematosus (SLE) in the seven major markets, with approximately 80-90% of these cases in women between 45 and 64 years of age. The number of prevalent cases is expected to increase to approximately 420,000 cases by 2020.
Features and benefits
- Gain insight to market potential, including a robust 10-year epidemiology forecast of prevalent systemic lupus erythematosus cases.
- Understand the key epidemiologic risk factors associated with systemic lupus erythematosus.
Highlights
- Between 2010 and 2020, Datamonitor expects to see an overall increase in the number of prevalent cases of systemic lupus erythematosus in the US, France, Spain, and the UK. The largest increase is expected in the US. This is due to the fact that the population in women aged 45-64 is increasing in these countries.
- A decrease in prevalent cases of systemic lupus erythematosus is expected in Japan, Germany, and Italy. The largest decrease is expected in Japan. This is due to the fact that the population in women aged 45-64 is decreasing in these countries, along with the population on the whole.
- Women aged between 45 and 64 are expected to constitute approximately 80-90% of cases of systemic lupus erythematosus.
Your key questions answered
- What are the most robust sources for systemic lupus erythematosus prevalence?
- How will the patient population change of the next decade in the US, Japan, and the five major EU markets (France, Germany, Italy, Spain, and the UK)?
- How do changes in population structure and risk factors affect the trend in prevalent systemic lupus erythematosus cases?
|
|
|
|
